Phase II Study of Neoadjuvant IMC-A12 Combined With Androgen Deprivation Prior to Prostatectomy.
Phase of Trial: Phase II
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Cixutumumab (Primary) ; Bicalutamide; Goserelin
- Indications Prostate cancer
- Focus Biomarker; Therapeutic Use
- 25 Nov 2011 Actual end date Nov 2011 added as reported by ClinicalTrials.gov.
- 25 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.